A detailed history of Ameriprise Financial Inc transactions in Sanofi stock. As of the latest transaction made, Ameriprise Financial Inc holds 656,667 shares of SNY stock, worth $31.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
656,667
Previous 399,796 64.25%
Holding current value
$31.4 Million
Previous $19.4 Million 95.19%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$48.54 - $58.53 $12.5 Million - $15 Million
256,871 Added 64.25%
656,667 $37.9 Million
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $2.36 Million - $2.62 Million
52,013 Added 14.96%
399,796 $19.4 Million
Q1 2024

May 15, 2024

BUY
$45.75 - $52.48 $7.58 Million - $8.7 Million
165,714 Added 91.02%
347,783 $16.9 Million
Q4 2023

Feb 14, 2024

SELL
$43.13 - $54.79 $1.12 Million - $1.42 Million
-25,900 Reduced 12.45%
182,069 $9.05 Million
Q3 2023

Nov 14, 2023

SELL
$50.95 - $55.2 $6.97 Million - $7.56 Million
-136,879 Reduced 39.69%
207,969 $11.2 Million
Q2 2023

Aug 14, 2023

SELL
$50.45 - $57.18 $718,761 - $814,643
-14,247 Reduced 3.97%
344,848 $18.6 Million
Q1 2023

May 15, 2023

BUY
$45.86 - $54.45 $2.83 Million - $3.36 Million
61,696 Added 20.75%
359,095 $19.5 Million
Q4 2022

Feb 14, 2023

SELL
$38.86 - $48.55 $592,148 - $739,804
-15,238 Reduced 4.87%
297,399 $14.4 Million
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $406,516 - $1.1 Million
10,922 Added 3.62%
312,637 $11.9 Million
Q2 2022

Aug 15, 2022

BUY
$48.99 - $57.46 $1.26 Million - $1.48 Million
25,703 Added 9.31%
301,715 $15.1 Million
Q1 2022

May 16, 2022

BUY
$48.48 - $53.65 $1.13 Million - $1.25 Million
23,308 Added 9.22%
276,012 $14.2 Million
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $2.92 Million - $3.24 Million
61,939 Added 32.47%
252,704 $12.7 Million
Q3 2021

Nov 15, 2021

SELL
$47.89 - $53.12 $7.1 Million - $7.87 Million
-148,175 Reduced 43.72%
190,765 $9.2 Million
Q2 2021

Aug 16, 2021

BUY
$49.36 - $54.25 $1.51 Million - $1.66 Million
30,583 Added 9.92%
338,940 $17.8 Million
Q1 2021

May 17, 2021

SELL
$45.46 - $50.51 $899,335 - $999,239
-19,783 Reduced 6.03%
308,357 $15.3 Million
Q4 2020

Feb 12, 2021

SELL
$45.3 - $51.62 $885,026 - $1.01 Million
-19,537 Reduced 5.62%
328,140 $15.9 Million
Q3 2020

Nov 16, 2020

BUY
$49.47 - $53.77 $2.75 Million - $2.99 Million
55,580 Added 19.03%
347,677 $17.4 Million
Q2 2020

Aug 14, 2020

SELL
$42.91 - $52.5 $4.4 Million - $5.38 Million
-102,436 Reduced 25.96%
292,097 $14.9 Million
Q1 2020

May 15, 2020

BUY
$38.02 - $51.66 $6.7 Million - $9.11 Million
176,293 Added 80.78%
394,533 $17.2 Million
Q4 2019

Feb 14, 2020

BUY
$44.25 - $50.86 $379,620 - $436,327
8,579 Added 4.09%
218,240 $11 Million
Q3 2019

Nov 14, 2019

SELL
$40.34 - $46.64 $153,735 - $177,745
-3,811 Reduced 1.79%
209,661 $9.72 Million
Q2 2019

Aug 14, 2019

BUY
$40.43 - $44.3 $1.18 Million - $1.29 Million
29,074 Added 15.77%
213,472 $9.23 Million
Q1 2019

May 15, 2019

BUY
$40.83 - $45.43 $2.56 Million - $2.85 Million
62,787 Added 51.63%
184,398 $8.17 Million
Q4 2018

Feb 14, 2019

BUY
$41.48 - $45.59 $371,536 - $408,349
8,957 Added 7.95%
121,611 $5.28 Million
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $7.88 Million - $8.83 Million
-196,924 Reduced 63.61%
112,654 $5.03 Million
Q2 2018

Aug 14, 2018

BUY
$37.63 - $41.22 $1.66 Million - $1.82 Million
44,177 Added 16.65%
309,578 $12.4 Million
Q1 2018

May 15, 2018

SELL
$38.98 - $45.76 $1.67 Million - $1.96 Million
-42,759 Reduced 13.88%
265,401 $10.6 Million
Q4 2017

Feb 12, 2018

SELL
$42.86 - $50.61 $3.52 Million - $4.16 Million
-82,187 Reduced 21.05%
308,160 $13.3 Million
Q3 2017

Nov 07, 2017

BUY
$47.04 - $50.34 $18.4 Million - $19.7 Million
390,347
390,347 $19.4 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.